ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the American College of Cardiology

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/EHL176PMID 16904574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term efficacy of flecainide in paroxysmal atrial fibrillation.

  2009cited by this paper
• Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation.

  2009cited by this paper
• Direct current countershock complications.

  2009cited by this paper
• Advances in Surgical Treatment of Atrial Fibrillation

  2007cited by this paper
• Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency

  2006cited by this paper
• Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

  2006cited by this paper
• Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

  2006cited by this paper
• Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.

  2006cited by this paper
• Amiodarone versus sotalol for atrial fibrillation.

  2005cited by this paper
• Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study

  2005cited by this paper
• Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery

  2005cited by this paper
• Ximelagatran--promises and concerns.

  2005cited by this paper
• Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

  2005cited by this paper
• Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

  2005cited by this paper
• Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

  2005cited by this paper
• Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack

  2005cited by this paper
• Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

  2005cited by this paper
• Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study)

  2005cited by this paper
• Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the

  2005cited by this paper
• Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation.

  2005cited by this paper
• N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

  2005cited by this paper
• Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.

  2005cited by this paper
• Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.

  2005cited by this paper
• Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans

  2005cited by this paper
• Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

  2005cited by this paper
• Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.

  2005cited by this paper
• Obesity and the risk of new-onset atrial fibrillation.

  2005cited by this paper
• Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast

  2005cited by this paper
• Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

  2005cited by this paper
• Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

  2005cited by this paper
• Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.

  2005cited by this paper
• Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas

  2005cited by this paper
• Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

  2005cited by this paper
• Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

  2005cited by this paper
• Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease

  2005cited by this paper
• Prophylaxis against postoperative atrial fibrillation: current progress and future directions.

  2005cited by this paper
• Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

  2005cited by this paper
• Rate versus rhythm control in the management of patients with atrial fibrillation

  2005cited by this paper
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2005cited by this paper
• Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies

  2005cited by this paper
• Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence

  2005cited by this paper
• Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

  2005cited by this paper
• Left Atrial–Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation

  2004cited by this paper
• Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.

  2004influential reference
• Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.

  2004cited by this paper
• Cost of care distribution in atrial fibrillation patients: the COCAF study.

  2004cited by this paper
• Spontaneous termination of ventricular fibrillation

  2004cited by this paper
• Theoretical possibilities for the development of novel antiarrhythmic drugs.

  2004cited by this paper
• Pulmonary Vein Antrum Isolation:

  2004cited by this paper
• Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation

  2004cited by this paper
• Obesity and the risk of new-onset atrial fibrillation.

  2004cited by this paper
• Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

  2004cited by this paper
• Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation

  2004cited by this paper
• Pharmacology of cardiac potassium channels.

  2004cited by this paper
• A multicenter risk index for atrial fibrillation after cardiac surgery.

  2004cited by this paper
• Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension.

  2004cited by this paper
• Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

  2004cited by this paper
• Fish intake and risk of incident atrial fibrillation.

  2004cited by this paper
• Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]).

  2004cited by this paper
• Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation.

  2004cited by this paper
• “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

  2004cited by this paper
• Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation.

  2004cited by this paper
• The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.

  2004cited by this paper
• Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial

  2004cited by this paper
• Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.

  2004cited by this paper
• Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting.

  2004cited by this paper
• Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).

  2004influential reference
• Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial

  2004cited by this paper
• Pharmacological rate control of atrial fibrillation.

  2004influential reference
• Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin

  2004cited by this paper
• A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

  2004cited by this paper
• Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

  2004cited by this paper
• Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

  2004cited by this paper
• Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation.

  2004cited by this paper
• A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation.

  2004cited by this paper
• Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation.

  2004cited by this paper
• Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.

  2004cited by this paper
• Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.

  2004cited by this paper
• Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study

  2004cited by this paper
• Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.

  2004cited by this paper
• A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation.

  2004cited by this paper
• Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.

  2004cited by this paper
• Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs

  2004cited by this paper
• Rate versus rhythm control in atrial fibrillation.

  2004cited by this paper
• Female preponderance in ibutilide-induced torsade de pointes.

  2004cited by this paper
• Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

  2004cited by this paper
• Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation: A Prospective Randomized Study Comparing Circumferential Pulmonary Vein Ablation With a Modified Approach

  2004cited by this paper
• Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

  2004cited by this paper
• Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

  2004cited by this paper
• Advances in surgical treatment of atrial fibrillation.

  2004cited by this paper
• The Who, What, Why, and How‐To Guide for Circumferential Pulmonary Vein Ablation

  2004cited by this paper
• Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia

  2004cited by this paper
• Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation

  2004cited by this paper
• Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study.

  2004cited by this paper
• Atrial Fibrillation Originating From Persistent Left Superior Vena Cava

  2004cited by this paper
• Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

  2004influential reference
• Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation

  2004cited by this paper

• Elevated Resting Heart Rate in Hospitalized Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk

  2026cites this paper
• Outcomes of 10 mg Rivaroxaban in Nonvalvular Atrial Fibrillation Patients With CrCl ≥ 50 mL/min: A Retrospective Cohort Study

  2025cites this paper
• Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence

  2025cites this paper
• Long-Term Outcomes of Concomitant Modified Cox-Maze and Mitral Surgery

  2025cites this paper
• Impact of Atrial Fibrillation Catheter Ablation on Functional Mitral Regurgitation.

  2025cites this paper
• Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models

  2025cites this paper
• Sinus rhythm maintenance in persistent atrial fibrillation: 12-lead ECG multiscale entropy characterization

  2025cites this paper
• Comparative efficacy and safety of anticoagulant therapies in coronary artery disease: a network meta-analysis of randomized controlled trials

  2025cites this paper
• Differential roles of eosinophils in cardiovascular disease

  2024cites this paper
• Left Atrial Dimension and CHA2DS2-VASc Score in Predicting Stroke in Patients with Rheumatic Atrial Fibrillation

  2024cites this paper
• Oral anticoagulation therapy initiation in patients with atrial fibrillation in relation to world region of origin: a register-based nationwide study

  2024cites this paper
• Impact of Sinus Rhythm Restoration on Mitral Regurgitation in Patients With Atrial Fibrillation: A Comparative Echocardiographic Study

  2024cites this paper
• Asthma is Associated with Higher Recurrence Rates of Atrial Fibrillation Following Catheter Ablation.

  2024cites this paper
• Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy

  2024cites this paper
• CHA2DS2-VASc Score in Predicting Visual Acuity Outcomes Following Retinal Vein Occlusion

  2024cites this paper
• Knowledge, attitude, and practice of Palestinian critical care nurses about hemodynamic instability in patients with cardiovascular diseases

  2024cites this paper
• Mid-to-long-term recurrence of atrial fibrillation in surgical treatment vs. catheter ablation: a meta-analysis using aggregated survival data

  2024cites this paper
• Physical Activity, Cardiorespiratory Fitness and Atherosclerotic Cardiovascular Disease: Part 1

  2024cites this paper
• Umfrage zur blutverdünnenden Therapie bei Patienten mit altersabhängiger Makuladegeneration

  2024cites this paper
• Association of Serum Uric Acid with Non-Valvular Atrial Fibrillation: A Retrospective Study in China

  2024cites this paper
• Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation

  2023cites this paper
• Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan

  2023cites this paper
• Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients

  2023cites this paper
• The Strengths and Weaknesses of Left Atrial Appendage Ligation or Exclusion (LARIAT, AtriaClip, Surgical Suture).

  2023cites this paper
• Diagnosis of atrial fibrillation based on AI-detected anomalies of ECG segments

  2023cites this paper
• Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban

  2023cites this paper
• The Experiences of Endurance Athletes With Atrial Fibrillation: Tensions and Takeaways.

  2023cites this paper
• Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting: A Double-Blind Randomized Comparative Trial

  2023cites this paper
• Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan

  2023cites this paper
• Feasibility and safety of a novel blunt tip concealed needle device for pericardial access in porcine models

  2023cites this paper
• Is atrial fibrillation associated with pulmonary embolism?

  2022cites this paper
• Silence is gilded: Atrial fibrillation in the golden years

  2022cites this paper
• Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation

  2022cites this paper
• Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?

  2022cites this paper
• Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction

  2022cites this paper
• Micro-mechanical blood clot testing using smartphones

  2022cites this paper
• Society for Maternal-Fetal Medicine (SMFM) Consult Series 61: Anticoagulation in pregnant patients with cardiac disease.

  2022cites this paper
• Prediction of Atrial Fibrillation in Hospitalized Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Mellitus Using Machine Learning: A Multicenter Retrospective Study

  2022cites this paper
• Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism

  2022cites this paper
• Predictive Value of Left Atrial Appendage Functional Parameters on Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation

  2022cites this paper
• Contemporary Review of Risk Scores in Prediction of Coronary and Cardiovascular Deaths

  2022cites this paper
• Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries

  2022cites this paper
• Correlation Between Serum Albumin and D-Dimer Levels in 909 Patients with Non-Valvular Atrial Fibrillation: A Retrospective Study from a Single Center in China

  2022cites this paper
• The Strengths and Weaknesses of Left Atrial Appendage Ligation or Exclusion (LARIAT, AtriaClip, Surgical Suture).

  2022cites this paper
• 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• Sex-Specific Prevalence, Incidence, and Mortality Associated With Atrial Fibrillation in Heart Failure.

  2021cites this paper
• Biomarkers in the clinical management of patients with atrial fibrillation and heart failure

  2021cites this paper
• Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation.

  2021cites this paper
• A New Vision at the Interface of Atrial Fibrillation and Stroke

  2021cites this paper
• The effect of contrast agents on the anticoagulant properties of oral factor Xa inhibitors

  2021cites this paper
• Clinical outcomes of atrial fibrillation with hyperthyroidism

  2021cites this paper
• Changes in anticoagulant prescription in a general hospital in 2008-2018

  2021cites this paper
• Treatment of Postoperative New Onset Atrial Fibrillation with Repolarization Delaying Agents after Heart Surgery

  2021cites this paper
• The Medico-economic Impacts of Marijuana Use on the Outcomes and In-hospital Mortality in Patients with Atrial Fibrillation – Nationwide Database study

  2021cites this paper
• Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis

  2021cites this paper
• Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System

  2021cites this paper
• Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

  2021cites this paper
• Laboratory predictors of clinical outcomes in patients with atrial fibrillation

  2021cites this paper
• Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?

  2021cites this paper
• Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US

  2020cites this paper
• Cause cardiache di embolia cerebrale

  2020cites this paper
• Anticoagulation in Patients with Aortic Stenosis and Atrial Fibrillation

  2020cites this paper
• Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms

  2020cites this paper
• Evaluating the cost-effectiveness of catheter ablation of atrial fibrillation.

  2020cites this paper
• Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario.

  2020cites this paper
• Comparative Analysis of Risk Stratification Scores in Atrial Fibrillation.

  2020cites this paper
• Scanner cardiaque : intérêt dans le bilan des douleurs thoraciques, dans le dépistage cardiovasculaire et dans le bilan pré-ablation de fibrillation auriculaire

  2020cites this paper
• Evaluation of late atrial enhancement by cardiac magnetic resonance imaging in patients with obstructive sleep apnea.

  2020cites this paper
• Quality of Life and Health Care Utilization in the CIRCA-DOSE Study.

  2020cites this paper
• MK-0448, a Specific Kv1.5 Inhibitor: Safety, Pharmacokinetics and Pharmacodynamic Electrophysiology in Experimental Animal Models and in Humans

  2020cites this paper
• Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management

  2020cites this paper
• The risk factors associated with treatment-related mortality in 16,073 kidney transplantation—A nationwide cohort study

  2020cites this paper
• Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors

  2020cites this paper
• Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

  2020cites this paper
• Factors Associated with a Large Decline in Renal Function or Progression to Renal Insufficiency in Hospitalized Atrial Fibrillation Patients with Early-Stage CKD.

  2020cites this paper
• Challenges for Anticoagulation in Atrial Fibrillation

  2020cites this paper
• Comparison of high‐power and conventional‐power radiofrequency energy deliveries in pulmonary vein isolation using unipolar signal modification as a local endpoint

  2020cites this paper
• Radiofrequency or cryoballoon ablation for index pulmonary vein isolation: What is the impact on long‐term clinical outcomes after repeat ablation?

  2020cites this paper
• Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients

  2020cites this paper
• The impact of the dominant frequency of body surface electrocardiography in patients with persistent atrial fibrillation

  2020cites this paper
• Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation

  2020cites this paper
• Ultra–high‐density mapping of conduction gaps and atrial tachycardias: Distinctive patterns following pulmonary vein isolation with cryoballoon or contact–force‐guided radiofrequency current

  2020cites this paper
• Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy.

  2020cites this paper
• Blanking period after radiofrequency ablation for atrial fibrillation guided by ablation lesion maturation based on serial MR imaging

  2020cites this paper
• Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study

  2020cites this paper
• Cryoballoon or radiofrequency ablation? Alternating technique for repeat procedures in patients with atrial fibrillation

  2020cites this paper
• CE_A_172935 1..6

  2020cites this paper
• Fibrilación auricular isquémica: cómo interpretar su fisiopatología y la decisión estratégica de tratamiento en torno a la arritmia

  2020cites this paper
• Antithrombotic therapy in patients with non-traumatic intracerebral haemorrhage and atrial fibrillation: A retrospective study

  2020cites this paper
• Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.

  2020cites this paper
• A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation-A Single-centre Retrospective Cohort Study in Singapore.

  2020cites this paper
• 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2020cites this paper
• A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany

  2020cites this paper
• Kobe University Repository : Kernel タイトル Tit le Re-evaluat ion of Clinical Features and Risk Factors of Acute Ischemic Stroke in Japanese Longevity Society 著者

  2019cites this paper
• Hematological Management of Neurocritical Care Patients

  2019cites this paper
• Reasons for successful clinical outcome following pulmonary vein isolation despite lack of persistent LA‐PV conduction block

  2019cites this paper
• Influence of various energy settings and overlap ratios on size and continuity of lesions in a laser balloon ablation in vitro model

  2019cites this paper
• Evidence for a Heritable Contribution to Atrial Fibrillation Associated With Fibrosis.

  2019cites this paper
• Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10‐Year Assessment

  2019cites this paper
• A Clinically Oriented Review of the Landmark Clinical Trials Comparing Warfarin and Aspirin to Novel Oral Anticoagulants in Atrial Fibrillation

  2019cites this paper